Adductor Canal Localization in Living and Cadaver

November 22, 2025 updated by: Yasin Usta, Ankara Etlik City Hospital

Determination of Adductor Canal Location by USG Measurements and Cadaver Correlation

The aim of this study is to define the starting and ending points of the adductor canal in adductor canal block (ACB) applications through distance measurements relative to the anterior superior iliac spine (ASIS) and the adductor tubercle. These measurements are performed using ultrasound (USG) and correlated with cadaveric data.

Key research questions addressed include:

  • Can the start and end points of the adductor canal be formulated along a line drawn between the ASIS and the adductor tubercle?
  • Is there a definable relationship between the block application site and anatomical landmarks such as the vastoadductor membrane (VAM), the apex of the femoral triangle, and other adjacent structures that facilitates localization?

By validating ultrasound measurements with cadaveric findings, the study aims to provide researchers with a more predictable and reliable method for determining the optimal site for adductor canal block administration.

Study Overview

Status

Not yet recruiting

Detailed Description

The aim of this study is to define the starting and ending points of the adductor canal (AC) in the context of adductor canal block (ACB) applications, through distance measurements related to the anterior superior iliac spine (ASIS) and adductor tubercle. These measurements are performed in two different planes: the first plane is along an imaginary line drawn between the ASIS and the femoral adductor tubercle, while the second plane is formed by the line between the ASIS and the base of the patella.

In these planes, distances were measured between the following points:

The distance between the adductor tubercle and ASIS,

The distance between ASIS and the base of the patella,

The distance between ASIS and the apex of the patella,

The distance between the midpoint of the inguinal fold and the base of the patella.

In patients, ultrasound was used to identify and mark the following anatomical points:

The apex of the iliopectineal fossa,

The first visible point of the vastoadductor membrane (VAM),

The point where the sartorius muscle ends with the intersection of the adductor longus and begins its contact with the edge of the adductor magnus point

The point where the adductor hiatus is located.

Additionally, in patients where visible, the descending genicular artery was also marked.

The position of the femoral artery in relation to the VAM (medial, middle, or lateral) was noted, as well as the location where the femoral artery intersects the adductor magnus and sartorius, and the depth from the skin to the adductor hiatus. Circumferential measurements of the thigh were also taken at these points.

Some of the data obtained was compared with anatomical measurements obtained through cadaveric dissection.

Key Research Questions

Where are the starting and ending points of the adductor canal?

Can the adductor canal be defined along a line drawn between the ASIS and the adductor tubercle?

Is there a definable relationship between the block application site and anatomical landmarks such as the vastoadductor membrane (VAM), the apex of the femoral triangle, and other adjacent structures that facilitate localization?

By validating ultrasound measurements with cadaveric findings, the study aims to provide researchers with a more predictable and reliable method for determining the optimal site for adductor canal block applications

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

He study at Etlik City Hospital will include patients who meet the following criteria: ASA classification of 1, 2, or 3, indicating individuals who are healthy or have mild to moderate systemic disease without major functional limitation; a BMI below 35 to exclude participants with obesity-related comorbidities; and an age range of 18 to 65 to ensure a broad yet controlled sample while avoiding age-related confounding factors. All participants must also provide informed consent, confirming their understanding of the study's purpose, procedures, and potential risks.

Description

Inclusion Criteria:

ASA 1-2-3 patients

BMI <35

Ages 18-65

Those willing to participate in the study

Exclusion Criteria:

Those unwilling to participate in the study

Pregnant women

BMI >35

ASA 4-5-6 patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
ULTRASONOGRAPHIC PARTICIPANT GROUP
Participants will have ultrasound imaging of the adductor canal anatomy.
Cadaver Group
Anatomical measurements and adjacencies of the adductor canal will be examined on cadavers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
location of the adductor canal
Time Frame: Perioperative/Periprocedural
Determine the location of the adductor canal on an imaginary line drawn between the anterior superior iliac spine and the adductor tubercle..
Perioperative/Periprocedural

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determining the entry point for adductor canal block
Time Frame: Perioperative/Periprocedural
Standardization of the entry point for adductor canal block by defining the relationship of the canal to other structures
Perioperative/Periprocedural
Adductor Canal neighborhoods
Time Frame: Perioperative/Periprocedural
Detection of the canal by imaging the Vasto adductor membrane
Perioperative/Periprocedural
cadaver dissection
Time Frame: Perioperative/Periprocedural
Determining the compatibility of the data obtained in ultrasonographic imaging with the real anatomical structures after cadaver dissection
Perioperative/Periprocedural
adductor canal
Time Frame: Perioperative/Periprocedural
measuring adductor canal length
Perioperative/Periprocedural

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Müge Çakırca, Associate Professor, Ankara Etlik City Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 25, 2025

Primary Completion (Estimated)

December 30, 2025

Study Completion (Estimated)

February 1, 2026

Study Registration Dates

First Submitted

September 20, 2025

First Submitted That Met QC Criteria

November 22, 2025

First Posted (Actual)

November 25, 2025

Study Record Updates

Last Update Posted (Actual)

November 25, 2025

Last Update Submitted That Met QC Criteria

November 22, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • AEŞH-BADEK-2025-0249

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anatomy

Subscribe